Tischer A, Siedler A, Rasch G
Robert Koch-Institut, Berlin.
Gesundheitswesen. 2001 Nov;63(11):703-9. doi: 10.1055/s-2001-18413.
In Germany, as in the entire WHO Region Europe, the goal has been set to eliminate measles by the year 2007. In order to achieve this, high vaccination rates of >/= 95 % are necessary as well as an intensive surveillance consisting of a continuous record of the age and region-specific incidence, vaccination rates and the seroprevalence. Data on the vaccination status, recorded in the districts at the time of school entry, are collected centrally and evaluated at the RKI since 1998. The vaccination rate for the 1(st) dose against measles is on the average 84.6 % and for the 2(nd) dose 14.3 %. A nationwide sentinel established in 1999 with over 1200 medical practitioners permits an estimate of the country-wide measles incidence on the basis of the registered measles cases. Results from the year 2000 showed a very big difference between the old Federal States (mean incidence of 46.8 illness per 100 000) and the new Federal States (0.9 per 100 000). Most of those falling sick were unvaccinated (85.4 %), where 35 % refused the vaccination. Thirty-nine percent of the cases were examined in the laboratory and from these 58 % were clinically confirmed; 10 % of the cases occurred in those receiving one dose of vaccine and none in those receiving 2 doses. The age peak of the sick children was between 1 to 4 years of age. Measles notification is obligatory in Germany since January 2001. From these data, the incidence of the 1(st) quarter has been calculated. It varies widely depending on the State (e. g. Bavaria 5.7 / 100.000 vs < 0.5 % in new Federal States). The seroprevalance studies conducted in 1993 and in 1995/96 show large gaps in immunity of small children and suggests that the MMR vaccination may have been carried out too late. The elimination of measles in Germany can only be achieved if the vaccination rates are increased and the 1(st) MMR vaccination is performed as early as possible. In particular, the vaccination rates for the 2(nd) dose are inadequate to be able to reach those with vaccine failures in a greater proportion and to close the gaps of vaccination.
在德国,如同在世界卫生组织欧洲区域的其他地方一样,已设定目标要在2007年消除麻疹。为实现这一目标,需要达到大于或等于95%的高疫苗接种率,以及进行强化监测,包括持续记录特定年龄和地区的发病率、疫苗接种率及血清阳性率。自1998年起,在学校入学时由各区记录的疫苗接种状况数据被集中收集,并由德国罗伯特·科赫研究所进行评估。麻疹第一剂疫苗的接种率平均为84.6%,第二剂为14.3%。1999年设立的一个拥有1200多名医生的全国性哨点,使得能够根据登记的麻疹病例估算全国的麻疹发病率。2000年的结果显示,旧联邦州(每10万人中平均发病46.8例)和新联邦州(每10万人中0.9例)之间存在很大差异。大多数患病者未接种疫苗(85.4%),其中35%拒绝接种。39%的病例进行了实验室检查,其中58%得到临床确诊;10%的病例发生在接种一剂疫苗的人群中,接种两剂疫苗的人群中无发病情况。患病儿童的年龄高峰在1至4岁之间。自2001年1月起,德国规定必须报告麻疹病例。根据这些数据计算出了第一季度的发病率。发病率因州而异(例如巴伐利亚州为5.7/10万,而新联邦州低于0.5%)。1993年以及1995/1996年进行的血清阳性率研究表明,幼儿的免疫存在很大差距,这表明麻疹、腮腺炎、风疹联合疫苗接种可能开展得太晚。只有提高疫苗接种率并尽早进行第一剂麻疹、腮腺炎、风疹联合疫苗接种,德国才能实现消除麻疹的目标。特别是,第二剂疫苗的接种率不足以使更大比例的疫苗接种失败者得到覆盖,也无法填补疫苗接种差距。